![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Becton Dickinson’s Self-Collection HPV Test Receives CE Mark
Becton Dickinson’s Self-Collection HPV Test Receives CE Mark
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
Becton Dickinson has received CE mark certification for its Onclarity HPV Assay, a human papillomavirus test that can also help screen for cervical cancer.
Using the assay, women can collect vaginal samples at home and send them to a laboratory for processing on the company’s Viper LT or COR systems.
The assay identifies 14 high-risk forms of HPV in a single analysis and provides genotyping information from specimens for use in cervical cancer screening.
Upcoming Events
-
21Oct